ACC
<ѻýҕl>ACC: Is Chelation Plus Vitamins a Winning Combo?ѻýҕl>
SAN FRANCISCO -- Vitamins alone won't improve outcomes for patients who've had a heart attack, but they do appear to have additive benefits when given in conjunction with controversial chelation therapy, researchers reported here.
Mar 10, 2013
<ѻýҕl>ACC: Triglycerides Decreased with Rosuvastatin Therapyѻýҕl>
ATLANTA -- In a study that specifically scrutinized the effects of statin therapy on triglycerides, researchers said that rosuvastatin (Crestor) significantly reduced the blood lipid that has been linked to coronary artery disease better than placebo.
Mar 15, 2010
<ѻýҕl>ACC: Clopidogrel Black Box Likely to Have Immediate Clinical Impactѻýҕl>
ATLANTA -- The FDA's decision to add a black box warning to the label of clopidogrel (Plavix) came without warning to doctors attending the American College of Cardiology meeting here. But getting the word out to more than 13,000 cardiologists gathered in this city not an easy task.
Mar 14, 2010
<ѻýҕl>ACC: Senate Probe Finds Evidence that Drug Firms Worked to Delay ENHANCE Resultsѻýҕl>
CHICAGO -- E-mails made public today described outrage more than a year ago by the ENHANCE trial's principal investigator because he perceived that a drugmaker was withholding bad results about ezetimibe/simvastatin (Vytorin) for non-scientific reasons.
Mar 31, 2008
<ѻýҕl>ACC: Coronary Artery Disease Patients Should Have Low LDL Goal
ѻýҕl>
ATLANTA, March 10 - For all patients with stable coronary artery disease (CAD), the goal of therapy should be to get LDL cholesterol lower than 70 mg/dL, said Christie Ballantyne, M.D., director of the center for cardiovascular disease prevention at Baylor College of Medicine in Houston.
Mar 22, 2006